Global Sorafenib Market Growth 2023-2028

Report ID: 1358654 | Published Date: Jan 2025 | No. of Page: 71 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Sorafenib Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Sorafenib by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Sorafenib by Country/Region, 2017, 2022 & 2028
    2.2 Sorafenib Segment by Type
        2.2.1 Patented Drugs
        2.2.2 Generic Drugs
    2.3 Sorafenib Sales by Type
        2.3.1 Global Sorafenib Sales Market Share by Type (2017-2022)
        2.3.2 Global Sorafenib Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Sorafenib Sale Price by Type (2017-2022)
    2.4 Sorafenib Segment by Application
        2.4.1 Kidney Cancer
        2.4.2 Liver Cancer
        2.4.3 Thyroid Cancer
        2.4.4 Other
    2.5 Sorafenib Sales by Application
        2.5.1 Global Sorafenib Sale Market Share by Application (2017-2022)
        2.5.2 Global Sorafenib Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Sorafenib Sale Price by Application (2017-2022)
3 Global Sorafenib by Company
    3.1 Global Sorafenib Breakdown Data by Company
        3.1.1 Global Sorafenib Annual Sales by Company (2020-2022)
        3.1.2 Global Sorafenib Sales Market Share by Company (2020-2022)
    3.2 Global Sorafenib Annual Revenue by Company (2020-2022)
        3.2.1 Global Sorafenib Revenue by Company (2020-2022)
        3.2.2 Global Sorafenib Revenue Market Share by Company (2020-2022)
    3.3 Global Sorafenib Sale Price by Company
    3.4 Key Manufacturers Sorafenib Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Sorafenib Product Location Distribution
        3.4.2 Players Sorafenib Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sorafenib by Geographic Region
    4.1 World Historic Sorafenib Market Size by Geographic Region (2017-2022)
        4.1.1 Global Sorafenib Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Sorafenib Annual Revenue by Geographic Region
    4.2 World Historic Sorafenib Market Size by Country/Region (2017-2022)
        4.2.1 Global Sorafenib Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Sorafenib Annual Revenue by Country/Region
    4.3 Americas Sorafenib Sales Growth
    4.4 APAC Sorafenib Sales Growth
    4.5 Europe Sorafenib Sales Growth
    4.6 Middle East & Africa Sorafenib Sales Growth
5 Americas
    5.1 Americas Sorafenib Sales by Country
        5.1.1 Americas Sorafenib Sales by Country (2017-2022)
        5.1.2 Americas Sorafenib Revenue by Country (2017-2022)
    5.2 Americas Sorafenib Sales by Type
    5.3 Americas Sorafenib Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Sorafenib Sales by Region
        6.1.1 APAC Sorafenib Sales by Region (2017-2022)
        6.1.2 APAC Sorafenib Revenue by Region (2017-2022)
    6.2 APAC Sorafenib Sales by Type
    6.3 APAC Sorafenib Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Sorafenib by Country
        7.1.1 Europe Sorafenib Sales by Country (2017-2022)
        7.1.2 Europe Sorafenib Revenue by Country (2017-2022)
    7.2 Europe Sorafenib Sales by Type
    7.3 Europe Sorafenib Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Sorafenib by Country
        8.1.1 Middle East & Africa Sorafenib Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Sorafenib Revenue by Country (2017-2022)
    8.2 Middle East & Africa Sorafenib Sales by Type
    8.3 Middle East & Africa Sorafenib Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Sorafenib
    10.3 Manufacturing Process Analysis of Sorafenib
    10.4 Industry Chain Structure of Sorafenib
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Sorafenib Distributors
    11.3 Sorafenib Customer
12 World Forecast Review for Sorafenib by Geographic Region
    12.1 Global Sorafenib Market Size Forecast by Region
        12.1.1 Global Sorafenib Forecast by Region (2023-2028)
        12.1.2 Global Sorafenib Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Sorafenib Forecast by Type
    12.7 Global Sorafenib Forecast by Application
13 Key Players Analysis
    13.1 Bayer
        13.1.1 Bayer Company Information
        13.1.2 Bayer Sorafenib Product Offered
        13.1.3 Bayer Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Bayer Main Business Overview
        13.1.5 Bayer Latest Developments
    13.2 Natco Pharma
        13.2.1 Natco Pharma Company Information
        13.2.2 Natco Pharma Sorafenib Product Offered
        13.2.3 Natco Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Natco Pharma Main Business Overview
        13.2.5 Natco Pharma Latest Developments
    13.3 Cipla
        13.3.1 Cipla Company Information
        13.3.2 Cipla Sorafenib Product Offered
        13.3.3 Cipla Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Cipla Main Business Overview
        13.3.5 Cipla Latest Developments
    13.4 Mylan
        13.4.1 Mylan Company Information
        13.4.2 Mylan Sorafenib Product Offered
        13.4.3 Mylan Sorafenib Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Mylan Main Business Overview
        13.4.5 Mylan Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Sorafenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Sorafenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Patented Drugs
    Table 4. Major Players of Generic Drugs
    Table 5. Global Sorafenib Sales by Type (2017-2022) & (K Units)
    Table 6. Global Sorafenib Sales Market Share by Type (2017-2022)
    Table 7. Global Sorafenib Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Sorafenib Revenue Market Share by Type (2017-2022)
    Table 9. Global Sorafenib Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Sorafenib Sales by Application (2017-2022) & (K Units)
    Table 11. Global Sorafenib Sales Market Share by Application (2017-2022)
    Table 12. Global Sorafenib Revenue by Application (2017-2022)
    Table 13. Global Sorafenib Revenue Market Share by Application (2017-2022)
    Table 14. Global Sorafenib Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Sorafenib Sales by Company (2020-2022) & (K Units)
    Table 16. Global Sorafenib Sales Market Share by Company (2020-2022)
    Table 17. Global Sorafenib Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Sorafenib Revenue Market Share by Company (2020-2022)
    Table 19. Global Sorafenib Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Sorafenib Producing Area Distribution and Sales Area
    Table 21. Players Sorafenib Products Offered
    Table 22. Sorafenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Sorafenib Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Sorafenib Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Sorafenib Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Sorafenib Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Sorafenib Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Sorafenib Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Sorafenib Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Sorafenib Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Sorafenib Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Sorafenib Sales Market Share by Country (2017-2022)
    Table 35. Americas Sorafenib Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Sorafenib Revenue Market Share by Country (2017-2022)
    Table 37. Americas Sorafenib Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Sorafenib Sales Market Share by Type (2017-2022)
    Table 39. Americas Sorafenib Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Sorafenib Sales Market Share by Application (2017-2022)
    Table 41. APAC Sorafenib Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Sorafenib Sales Market Share by Region (2017-2022)
    Table 43. APAC Sorafenib Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Sorafenib Revenue Market Share by Region (2017-2022)
    Table 45. APAC Sorafenib Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Sorafenib Sales Market Share by Type (2017-2022)
    Table 47. APAC Sorafenib Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Sorafenib Sales Market Share by Application (2017-2022)
    Table 49. Europe Sorafenib Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Sorafenib Sales Market Share by Country (2017-2022)
    Table 51. Europe Sorafenib Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Sorafenib Revenue Market Share by Country (2017-2022)
    Table 53. Europe Sorafenib Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Sorafenib Sales Market Share by Type (2017-2022)
    Table 55. Europe Sorafenib Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Sorafenib Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Sorafenib Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Sorafenib Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Sorafenib Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Sorafenib Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Sorafenib Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Sorafenib Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Sorafenib Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Sorafenib Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Sorafenib
    Table 66. Key Market Challenges & Risks of Sorafenib
    Table 67. Key Industry Trends of Sorafenib
    Table 68. Sorafenib Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Sorafenib Distributors List
    Table 71. Sorafenib Customer List
    Table 72. Global Sorafenib Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Sorafenib Sales Market Forecast by Region
    Table 74. Global Sorafenib Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Sorafenib Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Sorafenib Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Sorafenib Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Sorafenib Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Sorafenib Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Sorafenib Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Sorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Sorafenib Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Sorafenib Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Sorafenib Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Sorafenib Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Sorafenib Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Sorafenib Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Sorafenib Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Sorafenib Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Bayer Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors
    Table 93. Bayer Sorafenib Product Offered
    Table 94. Bayer Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Bayer Main Business
    Table 96. Bayer Latest Developments
    Table 97. Natco Pharma Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors
    Table 98. Natco Pharma Sorafenib Product Offered
    Table 99. Natco Pharma Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Natco Pharma Main Business
    Table 101. Natco Pharma Latest Developments
    Table 102. Cipla Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors
    Table 103. Cipla Sorafenib Product Offered
    Table 104. Cipla Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. Cipla Main Business
    Table 106. Cipla Latest Developments
    Table 107. Mylan Basic Information, Sorafenib Manufacturing Base, Sales Area and Its Competitors
    Table 108. Mylan Sorafenib Product Offered
    Table 109. Mylan Sorafenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Mylan Main Business
    Table 111. Mylan Latest Developments
List of Figures
    Figure 1. Picture of Sorafenib
    Figure 2. Sorafenib Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Sorafenib Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Sorafenib Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Sorafenib Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Patented Drugs
    Figure 10. Product Picture of Generic Drugs
    Figure 11. Global Sorafenib Sales Market Share by Type in 2021
    Figure 12. Global Sorafenib Revenue Market Share by Type (2017-2022)
    Figure 13. Sorafenib Consumed in Kidney Cancer
    Figure 14. Global Sorafenib Market: Kidney Cancer (2017-2022) & (K Units)
    Figure 15. Sorafenib Consumed in Liver Cancer
    Figure 16. Global Sorafenib Market: Liver Cancer (2017-2022) & (K Units)
    Figure 17. Sorafenib Consumed in Thyroid Cancer
    Figure 18. Global Sorafenib Market: Thyroid Cancer (2017-2022) & (K Units)
    Figure 19. Sorafenib Consumed in Other
    Figure 20. Global Sorafenib Market: Other (2017-2022) & (K Units)
    Figure 21. Global Sorafenib Sales Market Share by Application (2017-2022)
    Figure 22. Global Sorafenib Revenue Market Share by Application in 2021
    Figure 23. Sorafenib Revenue Market by Company in 2021 ($ Million)
    Figure 24. Global Sorafenib Revenue Market Share by Company in 2021
    Figure 25. Global Sorafenib Sales Market Share by Geographic Region (2017-2022)
    Figure 26. Global Sorafenib Revenue Market Share by Geographic Region in 2021
    Figure 27. Global Sorafenib Sales Market Share by Region (2017-2022)
    Figure 28. Global Sorafenib Revenue Market Share by Country/Region in 2021
    Figure 29. Americas Sorafenib Sales 2017-2022 (K Units)
    Figure 30. Americas Sorafenib Revenue 2017-2022 ($ Millions)
    Figure 31. APAC Sorafenib Sales 2017-2022 (K Units)
    Figure 32. APAC Sorafenib Revenue 2017-2022 ($ Millions)
    Figure 33. Europe Sorafenib Sales 2017-2022 (K Units)
    Figure 34. Europe Sorafenib Revenue 2017-2022 ($ Millions)
    Figure 35. Middle East & Africa Sorafenib Sales 2017-2022 (K Units)
    Figure 36. Middle East & Africa Sorafenib Revenue 2017-2022 ($ Millions)
    Figure 37. Americas Sorafenib Sales Market Share by Country in 2021
    Figure 38. Americas Sorafenib Revenue Market Share by Country in 2021
    Figure 39. United States Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Canada Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Mexico Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Brazil Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 43. APAC Sorafenib Sales Market Share by Region in 2021
    Figure 44. APAC Sorafenib Revenue Market Share by Regions in 2021
    Figure 45. China Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Japan Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 47. South Korea Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Southeast Asia Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 49. India Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Australia Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Europe Sorafenib Sales Market Share by Country in 2021
    Figure 52. Europe Sorafenib Revenue Market Share by Country in 2021
    Figure 53. Germany Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 54. France Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 55. UK Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Italy Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Russia Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Middle East & Africa Sorafenib Sales Market Share by Country in 2021
    Figure 59. Middle East & Africa Sorafenib Revenue Market Share by Country in 2021
    Figure 60. Egypt Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 61. South Africa Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Israel Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Turkey Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 64. GCC Country Sorafenib Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Manufacturing Cost Structure Analysis of Sorafenib in 2021
    Figure 66. Manufacturing Process Analysis of Sorafenib
    Figure 67. Industry Chain Structure of Sorafenib
    Figure 68. Channels of Distribution
    Figure 69. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Sorafenib Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Sorafenib Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Sorafenib Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports